[Tackling diagnostic odysseys: a priority shared by Filnemus and AFM-Téléthon]

Biomarkers in facioscapulohumeral muscular dystrophy.

Current opinion in neurology·2026

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).

Mayo Clinic proceedings. Innovations, quality & outcomes·2026

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

Proceedings of the National Academy of Sciences of the United States of America·2026

Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.

European journal of neurology·2026

2025 update of the National French consensus on gene lists for the diagnosis of muscle diseases using high-throughput sequencing.

Journal of neuromuscular diseases·2026

Phenotype-specific muscle proteomic profiling in titinopathies.

Acta neuropathologica communications·2026

[Serial cloners of Yamanashi].

Medecine sciences : M/S·2026

[Long COVID: between a syndromic framework and an etiological imperative].

Medecine sciences : M/S·2026

[The Edmonton transplantation protocol, 25 years later: toward remission of type 1 diabetes?]

Medecine sciences : M/S·2026

[Bioinformatics and omics analyses: chronology of a new scientific approach].

Medecine sciences : M/S·2026

[The 2025 Nobel Prize: regulatory T lymphocytes, the long-neglected "immunosuppressive cells". A brief history of a scientific renaissance and its emergence in France].

Medecine sciences : M/S·2026

[Contributions of seeding amplification assays to the diagnosis of synucleinopathies].

Medecine sciences : M/S·2026

Quantification of tadalafil in HLMs using an ultrafast UPLC-MS/MS method to assess metabolic stability, including in silico analysis of metabolic lability, DEREK alerts, and ADME characteristics.

Analytical methods : advancing methods and applications·2026

When an AI-generated diagnosis begins to matter: the AI consequence point.

Diagnosis (Berlin, Germany)·2026

Central Nervous System Aspergillosis: Advances in Diagnosis, Therapeutics, and Multidisciplinary Management (2026 Update).

Mycoses·2026

NAFLD becomes MASLD, frequency and characteristics of non-obese metabolic dysfunction associated steatotic liver disease (MASLD) among patients seeking care at a tertiary medical facility.

JPMA. The Journal of the Pakistan Medical Association·2026

A Dual-Mode In Situ EV-miRNA Profiling Platform for Machine-Learning-Assisted Gastric Cancer Liquid Biopsy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Applications of AI-assisted interpreter Raman spectroscopy platform for rapid and accurate cefotaxime-resistant Escherichia coli classification.

Analytica chimica acta·2026

Related Experiment Videos

[Tackling diagnostic odysseys: a priority shared by Filnemus and AFM-Téléthon]

Related Concept Videos

Biomarkers in facioscapulohumeral muscular dystrophy.

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.

2025 update of the National French consensus on gene lists for the diagnosis of muscle diseases using high-throughput sequencing.

Phenotype-specific muscle proteomic profiling in titinopathies.

[Serial cloners of Yamanashi].

[Long COVID: between a syndromic framework and an etiological imperative].

[The Edmonton transplantation protocol, 25 years later: toward remission of type 1 diabetes?]

[Bioinformatics and omics analyses: chronology of a new scientific approach].

[The 2025 Nobel Prize: regulatory T lymphocytes, the long-neglected "immunosuppressive cells". A brief history of a scientific renaissance and its emergence in France].

[Contributions of seeding amplification assays to the diagnosis of synucleinopathies].

Quantification of tadalafil in HLMs using an ultrafast UPLC-MS/MS method to assess metabolic stability, including in silico analysis of metabolic lability, DEREK alerts, and ADME characteristics.

When an AI-generated diagnosis begins to matter: the AI consequence point.

Central Nervous System Aspergillosis: Advances in Diagnosis, Therapeutics, and Multidisciplinary Management (2026 Update).

NAFLD becomes MASLD, frequency and characteristics of non-obese metabolic dysfunction associated steatotic liver disease (MASLD) among patients seeking care at a tertiary medical facility.

A Dual-Mode In Situ EV-miRNA Profiling Platform for Machine-Learning-Assisted Gastric Cancer Liquid Biopsy.

Applications of AI-assisted interpreter Raman spectroscopy platform for rapid and accurate cefotaxime-resistant Escherichia coli classification.

Related Experiment Videos

[Tackling diagnostic odysseys: a priority shared by Filnemus and AFM-Téléthon]

Related Concept Videos

Related Articles